Kyrgyzstan Third-Generation IVF PGT Technology: Detailed Explanation of Screenable Diseases and Scope
Kyrgyzstan third-generation IVF PGT technology can screen for chromosomal numerical abnormalities (Trisomy 21, Trisomy 18, Trisomy 13, etc.), chromosomal structural abnormalities (balanced translocation, Robertsonian translocation), and monogenic genetic diseases (thalassemia, SMA, cystic fibrosis, etc.). The specific types of screening depend on the PGT-A, PGT-M, PGT-SR technology type and laboratory testing platform configuration; not all genetic diseases can be detected.
Read More